Hexa Research
This presentation is the property of its rightful owner.
Sponsored Links
1 / 5

Sevoflurane, Isoflurane and Desflurane Market Analysis Till 2022 - Hexa Res... PowerPoint PPT Presentation


The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used by anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are very strong and cost less, with minimum damage to the ozone layer.

Download Presentation

Sevoflurane, Isoflurane and Desflurane Market Analysis Till ...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Sevoflurane isoflurane and desflurane market analysis till 2022 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

Sevoflurane, Isoflurane and Desflurane Market Analysis, Size,

Share, Growth, Industry Trends and Forecast to 2022 - Hexa

Research

The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion

by 2022 in comparison to USD 1.2 billion in 2014. These three chemicals are inhalation

agents and have been used by anesthesiologists, nurse anesthetists, and

anesthesiology assistants on a consistent basis. They are very strong and cost less,

with minimum damage to the ozone layer.

Browse Detail [email protected]://www.hexaresearch.com/research-

report/sevoflurane-isoflurane-desflurane-industry

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


Sevoflurane isoflurane and desflurane market analysis till 2022 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

Market Drivers

One of the primary factors, triggering expansion in the sevoflurane, isoflurane and

desflurane market includes cardiovascular and respiratory diseases affecting the

geriatric population. Rising cancer, orthopedic, spinal and gastro-intestinal cases have

also furthered the market. Cataract surgery is a major contributor to the global market

and will need a higher production of these chemicals.

Growing accidents and emergency cases also add income to the inhalation anesthesia

market. Universal insurance coverage as well as constant improvements in medical

infrastructure also ensure the development of the sevoflurane, isoflurane and

desflurane market. These agents are administered to patients prior surgery, making the

induction of general anesthesia much simpler.

A major factor hindering the market is the quantity of CO2 released in the environment,

leading to global warming. Actually, only about 5 percent of the gases are consumed

by patients. The rest are released into the atmosphere and make it unhealthy. The most

practical solution for this problem is the anesthetic recycling of products used during

the administration of general anesthesia.

Products Overview

Sevoflurane

Sevoflurane is one of the most commonly used volatile anesthetic agents. It is

administered to babies and children. Sevoflurane is ideal for patients with asthma or

sensitive air passages. But its side-effects include delirium and agitation. It can be

given quickly without the use of intravenous instruments.

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


Sevoflurane isoflurane and desflurane market analysis till 2022 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

Sevoflurane would capture over 70% of the worldwide sevoflurane, isoflurane and

desflurane market by 2022. The agent is expected to exceed USD 1 billion by the same

year. It’s widely utilized for being low-priced and possessing therapeutic benefits.

Isoflurane

Isoflurane is a halogen ether utilized frequently by veterinarians. It is administered

intravenously, relaxes the muscles and reduces pain. Isoflurane has also been used for

inducing sleepiness for long durations during surgery. It is expected to register a CAGR

of about 10% by 2022.

Desflurane

Desflurane is a halogen ether used in general anesthesia. Its effectiveness is one-fifth

of isoflurane. Desflurane cannot be administered orally and requires an electrically

heated dispenser to distribute the vapor. It is mostly administered to bariatric patients

and in cases of surgeries lasting for short durations.

Regional Overview

The United States has a large geriatric population. This has led the region of North

America to occupy the biggest share in the worldwide inhalation anesthesia market in

2014. Surgical ambulatory and inpatient procedures are the driving factors of North

America.

Asia Pacific will experience the fastest growth by 2022. This is owing to the rise of

chronic diseases and need for better health infrastructure in the region. Medical tourism

combined with insurance coverage will play a huge role in sustaining the growth of the

sevoflurane, isoflurane and desflurane market.

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


Sevoflurane isoflurane and desflurane market analysis till 2022 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

Key Players

The market is currently dominated by AbbVie and Baxter International. However, it can

expect strong competition from manufacturers like Lunan Pharmaceutical Group and

Piramal Enterprises.

Piramal Enterprises currently has isoflurane and sevoflurane production underway. It

will manufacture generic desflurane by 2016. AbbVie has sevoflurane and isoflurane

under production. Baxter International is the only one that manufactures all the three

products.

Anesthesia has some unhealthy effects. The recycling companies of Deltasorb

Technologies and Anesthetic Gas Reclamation reprocess anesthesia containers and

gases from hospital vents. Rising investments by the aforementioned players would

also accelerate the sales of the sevoflurane, isoflurane and desflurane market.

Browse Related Category Market Reports@

https://www.hexaresearch.com/research-category/pharmaceuticals-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports,

custom research and consulting services to a host of key industries across the globe. We

offer comprehensive business intelligence in the form of industry reports which help our

clients obtain clarity about their business environment and enable them to undertake

strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


Sevoflurane isoflurane and desflurane market analysis till 2022 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: [email protected]

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


  • Login